The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
https://www.tissueregenix.com/investors/shareholder-centre/commissioned-research-notes/
Afternoon, The details are included in the Hardman research doc published on the 20th June...It details that to get the next $5m tranche in April 2020 they will have to issue 91 million shares at the then expected share price of £0.06per share...its currently £0.045p per share and dropping hence 125 million shares now at £0.04p per share.
The sales are also projected to be down on previous forecasts for FY19 by 13% and FY20 by 16% with EPS showing a loss in FY20 too. Projected sales of £26m in FY21 will just about cover the escalating operating costs.This is a least a year behind against previous data and with continued dilution, hiring expensive heads of new teams this seems unlikely to set the share price fizzing. In my view the current price action is around these headwinds. May be proved wrong, which i hope but doesn't look promising. AGM on 27th June if anyone attending. Would welcome feedback
I have been a holder here since 2013 and seen the erosion of share holder value by dilution...In my view this drop has nothing to Woodford baling out, its more to do with the companies needs to issue another 125 million shares (at 0,04p) to cover the next $5 million tranche of cash. Jefferies has a price target of 10p on this and this will only go one way when more shares are issuesd.
Add to this the drop in sales forecasts for FY19 FY20 and FY21 means that its highly unlikely to be break even in FY20 as stated 4 months ago. The cash burn is increasing as the COGS goes up directly in proportion to the new heads of sales divisions and Directors they hire to ride the train...Unless this gets bought out and bare in mind we would be lucky yo get 5-6 times revenue then this will stagnate for next 2 years....
New web site....
for FY18 to be announced 23rd July 2018...Should be a market update in next 3 weeks?
Well today's the last day of FY18....Just remains to be seen if they have managed over the first four months of 2018 calendar year to reach EBITDA breakeven. If not there's no cash left. I cant remember ever seeing any FY19 guidance? Anyone??
That's a no then....
It seems the AGM is next Friday...30th June 2017. Perhaps there might be an update on the companies progress with the aquisition and Sales uplift
Pre-close trading update 24 May 2017 Full Year results announced 24 July 2017
I was once told that a company gets the share holders it deserves... It seems Tungsten attracts traders rather than Investors. I do not expect a running commentary but think it would be reasonable to provide a quarterly update.
the votes are in. Currently valued at �55m. The forward looking statements on Monday will be key to moving this. 25th July should tie in with the end of the 100 day plan since Prabhat came on board. Lets hope he has a plan to steal the lunch of some the established invoice factoring options out there.
At its CMD Tungsten reported it is on track to achieve break even on an EBITDA level by the end of FY17 and Q316 trading to end January 2016 was broadly in line with market expectations. The company expects that free cash at the end of FY16 should exceed £8m. Lets hope this has been achieved!
his money....http://www.telegraph.co.uk/business/2016/04/18/watchstone-rejects-truell-bid/
this is what is called capitulation......
So that was it....A 15 million sell declared at 16.43 today. This has been worked through over the last few days dropping the price. The only question is why the sale?
Not sure what is behind the breaking of the 0.19p threshold but looks like someone is shifting some shares around...lets hope we dont have any large scale shorts in the house.
The prelims and US update will be posted on the 19th May. There was sufficient cash to support the rollout and see them through this FY. Lets hope there is a start to an income stream.
Last year this was out via RNS on the 14th May..So could be some news by next Wednesday. I emailed the company last week for an update on the US launch but no reply as yet.....A bit of a tumble weed moment.
Blimey....A friend! No you have not missed anything. Its been eerily quiet. I thought we would have received an update ref US launch by now?
British Bulls view.... Let’s jump on our white horses and go for a bullish ride. The bullish pattern that was previously identified is finally confirmed and a BUY signal is generated. The market is telling you about a new profit. Do not miss this bullish opportunity. Pattern Description: This pattern occurs when two black days appear with equal closes in a downtrend. Matching Low indicates a bottom has been made, even though the new low was tested and there was no follow through, which is indicative of a good support price. All this could mean nothing of course, as it will all hinge on the update regarding the US launch. There was evidence on the net that the company has had its request for trademarks accepted; Dermapure & Nurturing and that there have been steps to set up a trial to access Dermapure's suitability to treat Diabetic foot ulcers. I did email 2 weeks ago and received the reply that an update would be forthcoming in due course..... Still waiting.